CannLabs Inc. (OTC: CANL), a leading provider of cloud-based analytics and scientific testing methods to the cannabis industry, recently announced that it has expanded its testing capabilities to include microbiological contaminants and harmful heavy metals. The company licenses its technology to laboratories based in Denver, CO and Hartford, CT.

“We are committed to investing in our technology to help the testing laboratories expand their testing capabilities,” said CannLabs Inc. CEO Mark Mirken in a recent press release discussing the expansion efforts. “We are pleased that the laboratory located in Denver will be able to extend its operating hours in order to meet its customers’ needs while leading the growing market for cannabis safety.”

CannLab’s investment into instrumentation for the Colorado lab includes Polymerase Chain Reaction (“PCR”) microbiological testing services, which can obtain accurate microbiological testing results in 24 to 48 hours. In addition, the laboratory will continue to offer Plating methods, which take 5 to 7 days and can be used concurrently with the newly implemented PCR testing services.

The Colorado laboratory also utilizes a state-of-the-art Microwave Accelerated Reactor System (“MARS”) Extractor, which enables it to extract heavy metals in a safe and efficient manner. With many heavy metals found in soils where cannabis is grown, the company removes elements like arsenic, cadmium, lead, and mercury, which can be especially damaging to patients with compromised immune function.

“This instrumentation allows the laboratory to offer heavy metal testing for cannabis, combined with an extensive range of microbial contaminant tests, we now offer comprehensive cannabis testing,” said CannLabs President Genifer Murray. “Through our expanded cannabis testing and consultancy platform, we can deliver a complete service to our clients that gives them the opportunity to discover and remediate any issues before their products reach the market.”

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: